CMIについての臨床的研究
スポンサーリンク
概要
- 論文の詳細を見る
The clinical evalution was made on the disribution of the four CMI regions in miscellaneous diseases. In this study, we inverstigated the usefullness of this questionnaire for finding neurotic tendencies in the patients and normal subjects as well as the relation between the result of CMI and MAS score obtained from them. The normal sample consisted of 263 male and 284 female healthy subjects, ages ranging from 16 to 63. The patients sample consisted of 601 males and 382 females, ages ranging from 15 to 65. They were 252 neuroses, 126 psychosomatics, 8 borderline cases, 92 manic-depressive psychoses, 156 schizophrenics, 10 atypical psychoses, 32 epileptics, 241,whiplash injuries, 30 hemiplegias and 36 climacteric disorders. The results were as folloes ; In normal subjects, the ratio of Region 1 in CMI was higher than that of other regions and then the ratio tended to dercease in the order of regions 1,2,3 and 4. Males included in Region 1 were 68.4% and females in Region 2 were 42.2%, The ratio distribution of CMI between the two sexes was markedly different. It seemed that the neurotic tendency generally was stronger in patients than in normal subjects, that is, the ratio distribution of CMI was signifficantly different between patients and normal subjects. The neurotic tendency was stronger in climacteric disorders than in other diseases and was likely to decrease in the order of climacteric disorder, neuroses, psychosomatics and psychoses. On the other hand, the patients with whiplash injury and hemiplegia tended to be more neurotic. 75.8% of neurotics were diagnosed as neurotic or possibly neurotic by CMI distribution of neuroses, hysterias and obsessive-compulsive neuroses were included in Region 3,while hypochondriases, anxiety neuroses and phobias were in Region 4 on the discriminative chart. Therefore this test not suitable distinguish the tyes of neuroses. The relationship between CMI and MAS was inverstigated in the normal sample consisting of 199 male and 145 female healthy subjects and the patient sample consisting of 448 males and 267 females. The CMI distribution was closely connected with MAS score, that is, many subjects included in Region 3 and 4 of CMI were in the high anxiety group of MAS, while, on the other hand, many subjects included in Regional and 2 were in the low anxiety group. The degree of neurotic tendency and anxiety was higher in patients in normal subjects. From these results it was concluded that the CMI was a useful questionnaire as a diagnostic test to evaluate the neurotic tendency in clinical practice.
- 日本心身医学会の論文
- 1975-10-01
著者
関連論文
- 39)知能優秀児の性格について(第11回日本精神身体医学会総会)
- 43)知能優秀児の性格について(小児科(5))(第11回日本精神身体医学会総会)
- 17.若年発症糖尿病者の社会適応状態とパースナリティーテストの成績について(一般講演)(第7回日本精神身体医学会九州地方会抄録)
- II-C-12 不登校患者の病態の分析-行動療法の立場から(小児・思春期III)
- I-E-12 施設入所老人の3年後の変化 : 評価尺度を用いた検討(老年期・ガン)
- II-D-56 老年脳卒中後遺症者の行動評価による検討 : 年代別および状態別の検討(老年期)
- IIE-33 施設入所老人における抑うつとQOL(老年期)
- II-D-29 特異な経過を示した全生活史健忘の1例(精神神経科II)
- II-D-17 特別養護老人ホーム入所老人における入院による影響 : 行動評価を用いた検討(メンタルヘルスII)
- 精神疾患患者の妊娠と出産
- II-D-51 寝たきり状態の老人の評価尺度による研究(老人)(一般口演)
- I-E-1 心理的ストレスが誘因となり発症した一過性全健忘の1例(精神神経I)(一般口演)
- II-C-15 甲状腺機能亢進および低下状態で幻聴が出現した慢性甲状腺炎と考えられる1症例(内分泌・代謝(1))
- 1B047 てんかん患者の視覚誘発電位に関する研究
- II-D-34 喫煙者における血小板内カルシウムの動員(精神神経科III)
- II-D-28 手首自傷の自験15例の臨床精神医学的検討(精神神経科II)
- 行動療法が奏功した痙性斜頸の1症例
- TPIによる精神疾患の臨床的研究
- うつ病者ならびに正常人における顕在性不安検査(MAS)およびベックうつ病評定法(BDI)の臨床的研究
- CMIについての臨床的研究
- II-D-6 産褥期精神障害の臨床的研究(産婦人科)
- II-D-5 精神疾患患者の妊娠と出産について(第2報)(産婦人科)
- 産褥期精神障害の臨床的研究 : II.身体的要因, 病前性格および転帰について
- 産褥期精神障害の臨床的研究 : I.病型分類について
- 58)催眠感受性の研究(第1報) : 神経症者の心理テストを中心として(第11回日本精神身体医学会総会)
- 64)催眠感受性の研究(第一報) : 神経症者の心理テストを中心として(精神生理(11))(第11回日本精神身体医学会総会)
- 4)自律神経テストとしてのメコリール賦活時の脉波(内分泌・代謝(7)) : 正常人並びに精神疾患患者における試み(内分泌・代謝(7))(第11回日本精神身体医学会総会)
- 3)精神疾患と自律神経・内分泌機能(第1報)(内分泌・代謝(7))(第11回日本精神身体医学会総会)
- The Modified Taylor Manifest Anxiety Scaleによる不安度評価の試み
- 3.鹿児島大学病院中検心理室4年間の経験から(一般講演)(第7回日本精神身体医学会九州地方会抄録)
- 87)心身症の治療効果と知能との関連性(治療)(第8回日本精神身体医学会総会)
- ロールシャッハ・テストからみた転換ヒステリー
- 不整脈の精神身体医学的観察 : 第3報 : 第6回日本精神身体医学会抄録
- 46)不整脈の精神身体医学的観察(第2報)
- 22 神経性食欲不振症の治療過程の分析 : 治療の進展が認められない時点での対応について(口頭発表-3,研究発表)